These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 2885440)

  • 1. Cellular mechanisms of action of atrial natriuretic factor.
    Gerzer R; Heim JM; Schütte B; Weil J
    Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of atrial natriuretic factor: clinical consequences.
    Gerzer R; Weil J; Strom T; Müller T
    Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
    Leitman DC; Murad F
    Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
    Drewett JG; Ziegler RJ; Trachte GJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is cyclic GMP a clinically useful marker for ANF action?
    Heim JM; Gottmann K; Weil J; Haufe MC; Gerzer R
    Z Kardiol; 1988; 77 Suppl 2():41-6. PubMed ID: 2841815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.
    Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ
    J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
    Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
    J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.
    Trachte GJ
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1227-33. PubMed ID: 8095549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
    Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
    Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.
    Leitman DC; Agnost VL; Tuan JJ; Andresen JW; Murad F
    Biochem J; 1987 May; 244(1):69-74. PubMed ID: 2889449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
    Drewett JG; Ziegler RJ; Trachte GJ
    J Pharmacol Exp Ther; 1990 Nov; 255(2):497-503. PubMed ID: 1978729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
    Rodriguez-Pascual F; Miras-Portugal MT; Torres M
    Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-genomic effects of tamoxifen on the activation of membrane-bound guanylate cyclase GC-A.
    Chen ZJ; Vetter M; Chang GD; Liu S; Ding Y; Chang CH
    J Pharm Pharmacol; 2003 Nov; 55(11):1539-45. PubMed ID: 14713365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic factor in spontaneously hypertensive rats: concentration changes with the progression of hypertension and elevated formation of cyclic GMP.
    Takayanagi R; Imada T; Grammer RT; Misono KS; Naruse M; Inagami T
    J Hypertens Suppl; 1986 Oct; 4(3):S303-7. PubMed ID: 2878070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiological and physiopathological aspects of the atrial natriuretic factor].
    Hamet P; Tremblay J
    Nephrologie; 1987; 8(1):7-12. PubMed ID: 2884582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.
    Waldman SA; Rapoport RM; Murad F
    J Biol Chem; 1984 Dec; 259(23):14332-4. PubMed ID: 6150043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins.
    Khurana ML; Pandey KN
    Arch Biochem Biophys; 1995 Jan; 316(1):392-8. PubMed ID: 7840642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity.
    Lee MA; West RE; Moss J
    J Clin Invest; 1988 Aug; 82(2):388-93. PubMed ID: 2457032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atrial natriuretic factor on renal function and cyclic GMP production.
    Blaine EH; Seymour AA; Marsh EA; Napier MA
    Fed Proc; 1986 Jun; 45(7):2122-7. PubMed ID: 2872085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.